Toxicologie

<p>Applications 3-Hydroxyoleylcarnitine is a derivative of Carnitine (L-Carnitine: C184110, D-Carnitine: C184105), an essential cofactor of fatty acid metabolism.<br>References Mitchell, M.E., et al.: Am. J. Clin. Nutr., 31, 293 (1978), Lango, R., et al.: Cardiovasc. Res., 51, 21 (2001), Vaz, F.M., et al.: Biochem. J., et al.: 361, 417 (2002), Karlic, H., et al.: Nutrition, 20, 709 (2004), O. Piermatti. et al.: Bioorg. Med. Chem., 16, 1444 (2008);<br></p>

<p>Applications 9,10-Phenanthrenequinone is used in the formation of spirophosphoranes containing acyclic 5-methyl-2-phenyl-2H-1,2,3-diazaphosphol-4-yl substituent.<br>References Mironov, V. F., et al.: Russ. J. Electrochem., 88, 430-438 (2018)<br></p>

<p>Applications 4-O-(E)-Feruloylquinic Acid is a phenolic acid with potential antioxidant and antifungal activities. Secondary metabolite in the coffee brewing process.<br>References Matei, M. et al.: J. Agri. Food Chem., 60, 12105 (2012); Dokli, I. et al.: Tetrahedron Asymm., 24, 785 (2013);<br></p>

<p>Applications Zinc salicylate trihydrate (CAS# 16283-36-6) is a useful research chemical compound.<br></p>

<p>Applications Benzyl 4-Nitrophenyl Carbonate is used as a reagent in the synthesis of Janus PEG-based dendrimers for use in combination therapy by controlled multi-drug loading and sequential release. Benzyl 4-Nitrophenyl Carbonate is also used as a reagent in the synthesis of Norfloxacin analogs which can exhibit antibacterial and antifungal activities under visible and UV light.<br>References Acton, A.L., et al.: Biomacromolecules, 14, 564 (2013); Bakhotmah, D.A., et al.: ISRN Org. Chem., 184754, 11 (2011)<br></p>

<p>Applications 5-epi Emtricitabine Carboxylic Acid is an impurity of 5-epi Emtricitabine (E524980); an epimer of Emtricitabine (E525000) which is a nucleoside reverse transcriptase inhibitor approved for treatment of HIV-1. Emtricitabine also has antagonistic activity against the hepatitis B virus.<br>References Jeong, L., et al.: J. Med. Chem., 36, 181 (1993); Lim, S. et al.: Arch. Intern. Med., 166, 49 (2006); Smith, K., et al.: AIDS, 23, 1547 (2009)<br></p>

<p>Applications (E)-1,1'-[2-(2,4-Difluorophenyl)-1-propene-1,3-diyl]bis-1H-1,2,4-triazole is an impurity of Fluconazole (F421000), an antifungal.<br>References Richard, K. et al.: Antimicrob. Ag. Chemother., 27, 832 (1985),<br></p>

<p>Applications (Z)-2'-Deschloro Luliconazole is a Luliconazole (L473770) impurity. Luliconazole is an azole antifungal drug.<br>References Uhida, K., et al.: J. Infect. Chemother., 10, 216 (2004); Niwano, ., et al.: Antimicro. Agents Chemother., 42, 967 (1998)<br></p>

<p>Applications Metazosulfuron is a herbicide used in paddy fields to control annual and perennial weeds.<br>References Lee, I., et. al.: The Korean Soc. Weed Sci., 31, 308 (2011)<br></p>

<p>Applications Sulfamonomethoxine-N1-glucosiduronic Acid, is a metabolite of Sulfamonomethoxine (S699145), found in human urine, after its administration. Sulfamonomethoxine is used as an antibacterial agent.<br>References Ueda, M.m et al.: Yakugaku Zasshi, 87, 455 (1967); Bridges, et al.: Biochem. J., et al.: 96, 829 (1965), Hong, Y.-L., et al.: Antimicrob. Agents Chemother., 39, 1756 (1995);<br></p>

<p>Applications A D2/D4-Dopamine receptor antagonist. A serotonergic receptor antagonist. A dibenzoxazepine antipsychotic agent.<br>References Shen, Y., et al.: J. Biol. Chem., 268, 18200 (1993), Fiorella, D., et al.: Psychopharmacology, 121, 347 (1995), Glusa, E., et al.: Br. J. Pharmacol., 130, 692 (2000)<br></p>

<p>Applications 5-Bromo-2-nitrophenol is a halonitrophenol with antifungal activity.<br>References Gershon, H., et al.: Monatshefte fuer Chemie, 126, 1161 (1995)<br></p>

<p>Applications 2,3-Dimethylbenzoquinone is a reagent in the preparation of hydroxycinnolines which has antifungal activity.<br>References Ryu, C., et al.: Bioorg. Med. Chem. Lett., 16, 1850 (2006)<br></p>

<p>Applications N-Boc Gatifloxacin N-Oxide is an intermediate used in the synthesis of Gatifloxacin N-Oxide (G250005), which is an impurity of Gatifloxacin (G250000), an antibacterial agent.<br>References Bauernfeind, A.: J. Antimicro. Chemother., 40, 639 (1997), Fukuda, H., et al.: Antimicrob. Ag. Chemother., 42, 1917 (1998),<br></p>

<p>Applications Ethyl 3-(4-bromo-2-chlorophenyl)-3-oxopropionate (CAS# 131994-22-4) is a useful research chemical compound.<br></p>

<p>Applications (3aR,4S,6aS)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one is an isomer of an impurity of Darunavir (D193500), a second generation HIV-1-protease inhibitor; structurally similar to amprenavir. Antiviral.<br>References Koh, Y., et al.: Antimicrob. Agents Chemother., 47, 3123 (2003), Arasteh, K., et al.: AIDS, 19, 943 (2005); Surleraux, D.L.N.G., et al.: J. Med. Chem., 48, 1813 (2005)<br></p>

<p>Applications (3S)-10-(1-Aminocyclopropyl)-9-fluoro-2,3-dihydro-6-hydroxy-3-methyl-7H-pyrido[1,2,3-de]-1,4-benzoxazin-7-one is an impurity and degredation product of Pazufloxacin, a fluorinated quinolone antibiotic.<br>References Demachi, Kumiko, et al.: Yakugaku Zasshi, 115(9), 716-31 (1995);Fukuoka, Y., et al.: Antimicrob. Ag. Chemother., 37, 384 (1993);Todo, Y., et al.: Chem. Pharm. Bull., 42, 2569 (1994)<br></p>

<p>Applications 3-(t-Butyldimethylsilyl)morphine N-Oxide is a by-product intermediate in synthesizing Morphinone N-Oxide ()M652352, a derivative of morphinone (M652350), which is a toxic metabolite of Morphine, a controlled substance.<br>References James, R., et al.: J. Pharmacol. Exp. Ther., 221, 708 (1982); Yamano, S., et al.: J. Biol. Chem., 260, 5259 (1985); Ishida, T., et al.: Drug Metab. Dispos., 17, 77 (1989); Yamano, S., et al.: Xenobiotica, 27, 645 (1997)<br></p>

<p>Applications (±)-Tramadol-d6 HCl (N,N-dimethyl-d6) (cis/trans mixture) (CAS# 1189374-50-2) is a useful isotopically labeled research compound.<br></p>

<p>Stability Very Hygroscopic<br>Applications Tenofovir Dimer is a dimer of Tenofovir (T018500). Tenofovir is a reverse transcriptase inhibitor. Used as an anti-HIV agent.<br>References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997), Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005), Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006), Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007),<br></p>

<p>Applications Isolopinavir-d9 is the isotope labelled analog of Isolopinavir, which is a metabolite of Lopinavir (L469480); a selective HIV protease inhibitor and antiviral.<br>References Sham, H.L., et al.: Antimicrob. Ag. Chemother., 42, 3218 (1998); Kumar, G.N., et al.: Drug Metab. Dispos., 27, 86 (1999); Murphy, R.L., et al.: Antiviral Ther., 4, Suppl. 3, 85 (1999)<br></p>

<p>Applications Efavirenz (E425000) potential synthetic impurity and degradation product.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Phelan, P., et al.: J. Chromatogr. Sci., 19, 13 (1981), Mangia, A., et al.: Anal. Chim. Acta., 149, 349 (1983), Careri, M., et al.: J. Chromatogr., 647, 79 (1993), van Beek, T., et al.: Phytochem. Anal., 6, 1 (1995),<br></p>

<p>Applications Stearoyl Ethanolamide-d4 is the labelled analogue of Stearoyl Ethanolamide (S686608), which is a prolific fatty acid ethanolamide produced by PLD hydrolysis of membrane phospholipids.<br>References Kasatkina, L. A., et al.: Biochem. Pharmacol. 174, 113783 (2020)<br></p>

<p>Applications Labelled analogue of (R)-Linezolid, an enatiomeric impurity of Linezolid (L466500).<br>References Bednarek, E. et al.: J. Chrom. A, 1193, 164 (2008); Nirogi, R. et al.: J. Chrom. Sci., 46, 764 (2008);<br></p>

<p>Applications 4-(Dimethylamino)butanal Hydrochloride is the HCl salt of D492530, which was one of the reagents in discovery of a novel series of quinolone a6 nicotinic acetylcholine receptor agonists.<br>References McDonald, I., et al.: Bioorganic Med. Chem. Lett., 23, 1684 (2013).<br></p>

<p>Applications 6-Methyl-4-oxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide is an intermediate of Dorzolamide Hydrochloride (D535100), a carbonic anhydrase inhibitor. Antiglaucoma agent.<br>References Jiang, X., et. al.: Yingyong Huagong, 36, 1215 (2007); Lippa, E.A., et al.: Ophthalmology, 98, 308 (1991); Wang, R.-F., et al.: Arch. Ophthalmol., 109, 1297 (1991); Whikehart, D., et al.: J. Ocul. Pharmacol., 7, 195 (1991); Sjoquist, B., et al.: Drug Metab. Dispos., 26, 745 (1998)<br></p>